Pro Medicus lands 7-year, A$23M contract with St. Luke’s Health System
Pro Medicus Limited [ASX: PME], through its wholly-owned US subsidiary Visage Imaging, Inc., has signed a 7-year, A$23M contract with St. Luke’s Health System, a not-for-profit healthcare provider based in Boise, Idaho. The agreement extends the healthcare informatics company’s reach across three US states.
The contract covers the Visage 7 Viewer and Visage 7 Workflow, with the platform to be implemented in the cloud. It represents further validation of Pro Medicus’s CloudPACS-led growth in North America.
When big ASX news breaks, our subscribers know first
Inside the St. Luke’s agreement
Under the deal, St. Luke’s will deploy the cloud-based Visage 7 Enterprise Imaging Platform, including both the Viewer and Workflow components, as a single, unified enterprise imaging platform across its network.
The agreement is structured on a transaction-based (transactional licensing) model with potential upside, an arrangement in which revenue is linked to volume. Planning for the rollout is set to commence immediately, based on Visage’s proven cloud-based implementation process.
The A$23M figure also matches the contract value Pro Medicus secured with the University of Maryland Medical System earlier in 2026, a 5-year deal covering Visage 7 Viewer and Workflow across an academic health network, suggesting consistent pricing benchmarks across mid-tier IDN clients.
Go-live is targeted for Q1 in the 2027 calendar year.
| Contract Term | Detail |
|---|---|
| Term | 7 years |
| Value | A$23M |
| Products | Visage 7 Viewer & Visage 7 Workflow |
| Model | Transaction-based (with potential upside) |
| Go-live | Q1 2027 calendar year |
Who is St. Luke’s Health System?
St. Luke’s provides context on the significance of this win for Pro Medicus, given its scale within the US healthcare market. Key details from the announcement include:
-
Idaho’s largest private employer and not-for-profit healthcare provider
-
Flagship facility: St. Luke’s Boise Medical Center
-
Spans 10 medical centers, including St. Luke’s Children’s Hospital
-
Serves patients across southern Idaho, eastern Oregon and northern Nevada
Dr Sam Hupert, Pro Medicus CEO
“St. Luke’s provides outstanding, community-based care to patients across southern Idaho, eastern Oregon and northern Nevada. They join an ever growing list of Visage 7 clients to opt for our fully cloud-based platform, which, as a result of our CloudPACS strategy, is becoming the standard in the North American healthcare IT market.”
What is Visage 7 and cloud-based enterprise imaging?
An enterprise imaging platform brings together medical imaging functions, including viewing and workflow management, across an entire health system. Rather than operating separate systems at each facility, a provider like St. Luke’s can access a single, unified platform.
The term “cloud-based,” referenced through Pro Medicus’s CloudPACS strategy, means the software runs on remote servers accessed over the internet rather than on hardware installed at each hospital site. Traditional systems are typically installed on-premise, requiring local infrastructure and maintenance.
For investors, the transactional licensing model carries a specific implication. Because revenue is tied to usage and volume, it can scale as the health system’s imaging activity grows, consistent with the transaction-based model with potential upside described in the announcement.
The transactional model’s organic growth mechanic is already demonstrable in practice: the Northwestern Medicine renewal, struck at higher per-transaction fees and increased minimum volume commitments, illustrated how rising imaging volumes translate into improved contract economics at the point of re-signing.
Why the deal strengthens the PME investment case
The St. Luke’s win reinforces Pro Medicus’s position that CloudPACS is becoming, in the words of CEO Dr Sam Hupert, “the standard in the North American healthcare IT market.” Each additional cloud contract adds to what management describes as an ever growing list of Visage 7 clients.
Hupert described the company’s pipeline as strong, spanning all market segments from tier 1 academic medical centers through to large and mid-sized IDNs (integrated delivery networks), such as St. Luke’s, as well as private imaging groups.
Dr Sam Hupert, Pro Medicus CEO
“Our pipeline remains strong and spans all market segments from tier 1 academic medical centers through to large and mid sized IDNs such as St Lukes as well as private imaging groups providing us with the largest addressable market (TAM) of any offering in the market.”
What happens next
The near-term roadmap for the St. Luke’s implementation follows a defined sequence:
-
Rollout planning commences immediately
-
Implementation proceeds based on Visage’s proven cloud-based process
-
Go-live is targeted for Q1 in the 2027 calendar year
Beyond the stated A$23M total contract value, the announcement does not disclose annual revenue splits, providing investors with a defined contract value but usage-dependent timing on realisation.
Don’t Miss the Next Healthcare Sector Winner
Get FREE breaking ASX healthcare news delivered to your inbox within minutes of release, complete with in-depth analysis. Join 20,000+ subscribers already staying ahead of the market the moment announcements drop. Click the “Free Alerts” button at Big News Blast to start receiving alerts before the broader market has a chance to react.